Effectiveness and safety of Rituximab in multiple sclerosis: an observational study from Southern Switzerland

Despite positive results from phase II and observational studies, Rituximab (RTX) is not currently approved for multiple sclerosis (MS) treatment and can only be used off-label. To characterize MS patients treated with RTX and investigate its effectiveness and safety in a clinical practice setting....

Celý popis

Uloženo v:

Podrobná bibliografie
Vydáno v:	PloS one Ročník 13; číslo 5; s. e0197415
Hlavní autoři:	Scotti, Barbara, Disanto, Giulio, Sacco, Rosaria, Guigli, Marilu’, Zecca, Chiara, Gobbi, Claudio
Médium:	Journal Article
Jazyk:	angličtina
Vydáno:	United States Public Library of Science 14.05.2018 Public Library of Science (PLoS)
Témata:	Analysis Autoimmune diseases Biology and Life Sciences Care and treatment Data processing Disease Drug therapy Females Immunotherapy Infections Interferon Laboratories Magnetic resonance imaging Medicine and Health Sciences Monoclonal antibodies Multiple sclerosis Neurology Observational studies Patient outcomes Patients People and Places Regression analysis Research and Analysis Methods Rheumatoid arthritis Rituximab Safety Safety and security measures Studies Switzerland Sweden
ISSN:	1932-6203, 1932-6203
On-line přístup:	Získat plný text
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!

Buďte první, kdo okomentuje tento záznam!